Clinical trial
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of…
NCT00482989 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00482989 |
|---|---|
| Title | A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus |
| Official title | A Phase 1b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI-545, a Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Patients With Systemic Lupus Erythematosus |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lupus |
| Intervention type | Biological, Other |
| Interventions | MEDI 545, Placebo |
| Enrollment | 183 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Jun 6, 2007 |
| Last update posted | Jul 11, 2012 |
| Countries | Argentina, Brazil, Chile, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: